Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04807868 · ClinicalTrials.gov registry record
AdventHealth Research Institute Non-Alcoholic Fatty Liver Disease Biobank and Registry (AVAIL)
A clinical trial of Non-alcoholic Fatty Liver Disease, sponsored by AdventHealth Translational Research Institute.
- Recruiting
- Registry status
- 1,250
- Enrollment target
- 1
- Study location
NCT04807868 is a study of Non-alcoholic Fatty Liver Disease that is actively recruiting participants, run by AdventHealth Translational Research Institute. The registered enrollment target is 1,250 participants, above the 165-participant average among 50 other Non-alcoholic Fatty Liver Disease trials with a reported enrollment target (658% higher). The trial reports 1 study location across 1 state.
The verdict
NCT04807868, a study of Non-alcoholic Fatty Liver Disease, is actively recruiting participants, sponsored by AdventHealth Translational Research Institute.
- RECRUITING
- Registry status
- 1,250 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to create a resource that will advance research that is focused on discovery of novel therapies, risk stratification, and aggressive interventions for those at highest risk for non-alcoholic fatty liver disease (NAFLD). To achieve this, we will generate a biobank of liver tissue collected during standard of care liver biopsies. Paired blood/urine samples, FibroScan and relevant data will also be collected.
Conditions Studied
Interventions
- OTHER Biospecimen Collection
- PROCEDURE Standard of care liver biopsy
- OTHER Fibroscan
Study Locations (1)
Florida
- AdventHealth Translational Research Institute - Orlando
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,250 participants |
| Start Date | 2021-04-22 |
| Est. Completion | 2026-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04807868
The ClinicalTrials.gov registry entry for NCT04807868 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,250 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 165-participant average among 50 other Non-alcoholic Fatty Liver Disease trials with a reported enrollment target (658% higher). The listed sponsor is AdventHealth Translational Research Institute, which has 54 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Non-alcoholic Fatty Liver Disease appearing as the primary indexed condition, and to 3 interventions - of which Biospecimen Collection is the first listed.
NCT04807868 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT04807868 about?
NCT04807868 is a clinical study titled "AdventHealth Research Institute Non-Alcoholic Fatty Liver Disease Biobank and Registry (AVAIL)". The purpose of this study is to create a resource that will advance research that is focused on discovery of novel therapies, risk stratification, and aggressive interventions for those at highest risk for non-alcoholic fatty liver disease (NAFLD). To achieve this, we will generate a biobank of live...
What is the current status of trial NCT04807868?
This trial is currently recruiting. The enrollment target is 1,250 participants. The study started on 2021-04-22. Estimated completion is 2026-03.
What conditions does trial NCT04807868 study?
This clinical trial studies the following conditions: Non-alcoholic Fatty Liver Disease.
What interventions are being tested in trial NCT04807868?
The interventions under investigation include: Biospecimen Collection (OTHER), Standard of care liver biopsy (PROCEDURE), Fibroscan (OTHER).
Who is sponsoring clinical trial NCT04807868?
This trial is sponsored by AdventHealth Translational Research Institute, which has 54 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04807868 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Non-alcoholic Fatty Liver Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
RECRUITING · Phase 3
-
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
RECRUITING · Phase 3
-
Intermittent Fasting for NAFLD in Adults
RECRUITING · NA
-
Moderately Carbohydrate-restricted Diet to Treat NAFLD in Adolescents
RECRUITING · NA
-
Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity (ATM)
RECRUITING
-
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.